Giuseppina Roscigno

1.8k total citations
36 papers, 1.5k citations indexed

About

Giuseppina Roscigno is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Giuseppina Roscigno has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 23 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Giuseppina Roscigno's work include MicroRNA in disease regulation (18 papers), RNA Interference and Gene Delivery (11 papers) and Extracellular vesicles in disease (7 papers). Giuseppina Roscigno is often cited by papers focused on MicroRNA in disease regulation (18 papers), RNA Interference and Gene Delivery (11 papers) and Extracellular vesicles in disease (7 papers). Giuseppina Roscigno collaborates with scholars based in Italy, United States and Spain. Giuseppina Roscigno's co-authors include Gerolama Condorelli, Cristina Quintavalle, Alessandra Affinito, Elvira Donnarumma, Danilo Fiore, Margherita Iaboni, Silvia Nuzzo, Valentina Russo, Assunta Adamo and Iolanda Scognamiglio and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Cancer Research.

In The Last Decade

Giuseppina Roscigno

35 papers receiving 1.5k citations

Peers

Giuseppina Roscigno
Wangjun Yan China
Alessandra Affinito Italy
Yong Zhu China
Shinobu Ueda Japan
Axel Seher Germany
Hongyun Xing China
Sara Bolis Switzerland
S. Füssel Germany
Wangjun Yan China
Giuseppina Roscigno
Citations per year, relative to Giuseppina Roscigno Giuseppina Roscigno (= 1×) peers Wangjun Yan

Countries citing papers authored by Giuseppina Roscigno

Since Specialization
Citations

This map shows the geographic impact of Giuseppina Roscigno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppina Roscigno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppina Roscigno more than expected).

Fields of papers citing papers by Giuseppina Roscigno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppina Roscigno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppina Roscigno. The network helps show where Giuseppina Roscigno may publish in the future.

Co-authorship network of co-authors of Giuseppina Roscigno

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppina Roscigno. A scholar is included among the top collaborators of Giuseppina Roscigno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppina Roscigno. Giuseppina Roscigno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roscigno, Giuseppina, Roberto Borea, Gianluca Russo, et al.. (2025). The potential application of stroma modulation in targeting tumor cells: Focus on pancreatic cancer and breast cancer models. Seminars in Cancer Biology. 113. 151–175. 2 indexed citations
2.
Affinito, Alessandra, Cristina Quintavalle, Giuseppina Roscigno, et al.. (2024). MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p. Cell Death Discovery. 10(1). 140–140. 22 indexed citations
3.
Pane, Katia, Cristina Quintavalle, Silvia Nuzzo, et al.. (2022). Comparative Proteomic Profiling of Secreted Extracellular Vesicles from Breast Fibroadenoma and Malignant Lesions: A Pilot Study. International Journal of Molecular Sciences. 23(7). 3989–3989. 8 indexed citations
4.
Briguori, Carlo & Giuseppina Roscigno. (2022). Low urine pH: a new marker for contrast-associated acute kidney injury?. EuroIntervention. 18(7). 527–528. 1 indexed citations
5.
Scognamiglio, Iolanda, Francesco Palma, Cristina Quintavalle, et al.. (2022). Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer. Molecular Therapy — Nucleic Acids. 28. 17–31. 44 indexed citations
6.
Esposito, Carla Lucia, Cristina Quintavalle, Deborah Rotoli, et al.. (2021). Targeting breast cancer exosomes with nucleic aptamers: innovative tools for early diagnosis and therapy. Siberian medical review. 2 indexed citations
7.
Esposito, Carla Lucia, Cristina Quintavalle, Deborah Rotoli, et al.. (2021). Identification of a novel RNA aptamer that selectively targets breast cancer exosomes. Molecular Therapy — Nucleic Acids. 23. 982–994. 33 indexed citations
8.
Roscigno, Giuseppina, Cristina Quintavalle, Giuseppe Biondi‐Zoccai, et al.. (2021). Urinary Dickkopf-3 and Contrast-Associated Kidney Damage. Journal of the American College of Cardiology. 77(21). 2667–2676. 30 indexed citations
9.
Affinito, Alessandra, Cristina Quintavalle, Carla Lucia Esposito, et al.. (2020). Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells. Molecular Therapy — Nucleic Acids. 20. 176–185. 36 indexed citations
10.
Roscigno, Giuseppina, et al.. (2020). Modulating the Crosstalk between the Tumor and the Microenvironment Using SiRNA: A Flexible Strategy for Breast Cancer Treatment. Cancers. 12(12). 3744–3744. 17 indexed citations
11.
Palma, Francesco, Alessandra Affinito, Silvia Nuzzo, et al.. (2020). miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer. Cancer Gene Therapy. 28(5). 413–426. 17 indexed citations
12.
Affinito, Alessandra, Cristina Quintavalle, Carla Lucia Esposito, et al.. (2019). The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells. Molecular Therapy — Nucleic Acids. 18. 99–109. 40 indexed citations
13.
Ng, Charlotte K.Y., G.G. Di Costanzo, Nadia Tosti, et al.. (2018). Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study. Annals of Oncology. 29(5). 1286–1291. 75 indexed citations
14.
Russo, Valentina, Alessandra Affinito, Giuseppina Roscigno, et al.. (2018). Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer Cells. Molecular Therapy — Nucleic Acids. 13. 334–346. 51 indexed citations
15.
Briguori, Carlo, Cristina Quintavalle, Michael Donahue, et al.. (2017). Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study. International Journal of Cardiology. 244. 112–118. 12 indexed citations
16.
Donnarumma, Elvira, Danilo Fiore, Giuseppina Roscigno, et al.. (2017). Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer. Oncotarget. 8(12). 19592–19608. 268 indexed citations
17.
Sosnowska, Marta, Francesca Bettazzi, Giuseppina Roscigno, et al.. (2016). Direct determination of small RNAs using a biotinylated polythiophene impedimetric genosensor. Biosensors and Bioelectronics. 87. 1012–1019. 52 indexed citations
18.
Iaboni, Margherita, Valentina Russo, Giuseppina Roscigno, et al.. (2016). Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL. Molecular Therapy — Nucleic Acids. 5. e289–e289. 59 indexed citations
19.
Quintavalle, Cristina, Davide Mangani, Giuseppina Roscigno, et al.. (2013). miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells. PLoS ONE. 8(9). e74466–e74466. 82 indexed citations
20.
Costanzo, Antonella Di, Giuseppina Roscigno, Maria Vivo, et al.. (2010). A dominant mutation etiologic for human tricho‐dento‐osseous syndrome impairs the ability of DLX3 to downregulate ΔNp63α. Journal of Cellular Physiology. 226(8). 2189–2197. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wangjun Yan Breakdown of academic impact, for papers by Alessandra Affinito Breakdown of academic impact, for papers by Yong Zhu Breakdown of academic impact, for papers by Shinobu Ueda Breakdown of academic impact, for papers by Axel Seher Breakdown of academic impact, for papers by Hongyun Xing Breakdown of academic impact, for papers by Sara Bolis Breakdown of academic impact, for papers by S. Füssel
Rankless by CCL
2026